DRIO Share Price Performance
US$0.55
-0.42 (-43.30%)
76.8% undervalued intrinsic discount
US$2.38
Fair Value
Price US$0.55
AnalystConsensusTarget US$2.38
Fair ValueUS$2.38
Share PriceUS$0.55
76.8% undervalued intrinsic discount
DRIO Community Narratives
AN
Fair Value US$2.38 76.8% undervalued intrinsic discount
Twill Integration And GLP-1 Focus Will Expand Health Solutions
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
DRIO Community Fair Values
- US$2.38FV76.8% undervalued intrinsic discount19.87%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative1users have followed this narrative12 days ago author updated this narrative
Recent DRIO News & Updates
No updates
DarioHealth Corp. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.67
- Gross Margin
- 69.41%
- Net Profit Margin
- -106.90%
- Debt/Equity Ratio
- 39.6%
DarioHealth Corp. Competitors
About DRIO
- Founded
- 2011
- Employees
- 199
- CEO
- WebsiteView website
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
U.S. Market Performance
- 7 Days: -1.2%
- 3 Months: 13.1%
- 1 Year: 22.8%
- Year to Date: 7.3%
Over the last 7 days, the market has dropped 1.2%, driven by a decline of 4.7% in the Consumer Discretionary sector. As for the longer term, the market has actually risen by 23% in the last year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading